Wireless home-based healthcare applications, services set to grow, analysis finds
DALLAS The U.S. market for wireless home-based healthcare applications and services will grow at a five-year cumulative annual growth rate of more than 180% and become a $4.4 billion industry by 2013, according to Parks Associates’ “Wireless Healthcare: Analysis & Forecasts” report released Aug. 5.
Parks predicts the push for healthcare reform from the Obama administration will ultimately boost adoption of wireless technologies in healthcare. The federal government is committed to promoting technology that improves healthcare efficiency, evident in the stimulus funds already allocated to electronic medical records adoption, and this focus will open new long-term opportunities for wireless providers, Parks executives predict.
“Wireless is an important crossover point for the healthcare sector and high-tech industry,” stated Harry Wang, director, Health & Mobile Product Research, Parks Associates. “Device and service connectivity is the model for future home care applications, and mobile networks will link a growing number of monitoring products to healthcare providers.”
The report suggests that mobile carriers will leverage their network resources to target vertical markets like healthcare through both wholesale and retail partnerships. Deals such as recent agreements from Verizon Wireless with LifeWatch and Qualcomm will become more commonplace as this market moves into wider availability.
Generex appoints Rubinfeld as chief scientific adviser
WORCESTER, Mass. One of the original founders of biotech giant Amgen has accepted an advisory position at a company that develops drugs delivered through the inner lining of the mouth.
Generex Biotechnology Corp. announced Tuesday the appointment of Joseph Rubinfeld as chief scientific adviser. The company said Rubinfeld would help the company develop and implement product commercialization plans for its drug delivery platform and synthetic vaccine platform technology programs.
Rubinfeld has worked in pharmaceutical and consumer product development for 50 years. His work has included helping develop the antibiotic amoxicillin and the first synthetic biodegradable detergent.
Becton, Dickinson and Co. to donate insulin injections through Direct Relief
FRANKLIN LAKES, N.J. A company that develops medical devices and technology plans to donate 5 million insulin syringes and pen needles to diabetes patients struggling to manage their disease because of the economic crisis.
Becton, Dickinson and Co. announced a nationwide program Tuesday to distribute the supplies through Direct Relief to more than 1,000 community health centers and free clinics.
“To avoid the debilitating and costly complications of diabetes, patients must effectively manage their conditions,” BD Medical – Diabetes Care president Linda Tharby said in a statement. “Insulin injections often play a vital role in this daily effort, and BD believes that patients who have fallen on tough times should not forego this critical part of their treatment regimen.”